Key market opportunities include advancements in gene and cell therapies, the integration of AI in pharmaceutical R&D, partnerships between major drug firms and smaller biotech companies, and emerging ...

LIMA, Peru, Dec. 1, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, announced a partnership with the ...

Researchers at the University of Maine are theorizing that human beings may be in the midst of a major evolutionary ...

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyze aggregates of ...

Myriad Genetics (MYGN) and PATHOMIQ entered into a strategic collaboration for Myriad to exclusively license PATHOMIQ_PRAD, PATHOMIQ’s AI technology platform for prostate cancer, in the United States.

The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, ...